J Gen Virol Try Microbiology Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dorsch, S.
Right arrow Articles by Modrow, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dorsch, S.
Right arrow Articles by Modrow, S.
Agricola
Right arrow Articles by Dorsch, S.
Right arrow Articles by Modrow, S.
Journal of General Virology (2001), 82, 191-199.
© 2001 Society for General Microbiology


Animal: DNA Viruses

The VP1-unique region of parvovirus B19: amino acid variability and antigenic stability

Simone Dorsch1, Bärbel Kaufmann2, Uwe Schaible1, Elke Prohaska1, Hans Wolf1 and Susanne Modrow1

Institut für Medizinische Mikrobiologie und Hygiene, Universität Regensburg, Franz-Josef-Strauß-Allee 11, 93053 Regensburg, Germany1
Institut für Physikalische Biochemie, Universität Potsdam, Im Biotechnologiepark, 14943 Luckenwalde, Germany2

Author for correspondence: Susanne Modrow. Fax +49 941 9446402. e-mail simone.dorsch{at}klinik.uni-regensburg.de

The unique region of structural protein VP1 of parvovirus B19 (erythrovirus B19) is important for eliciting neutralizing antibodies that are responsible for eliminating the virus from the peripheral blood and for inducing lifelong immunity. Neutralizing human MAbs bind a conformationally defined epitope spanning VP1 residues 30–42. The DNA sequence encoding the VP1-unique region was determined in parvovirus B19 isolated from peripheral blood and amniotic fluid of nine acutely infected pregnant women, five arthritis patients and two chronically infected children. The amino acid sequences of the VP1-unique region exhibited higher variability in comparison with other B19-specific proteins. To analyse the influence of amino acid variations on antibody binding and protein conformation, two variants of the VP1-unique region were selected and expressed in E. coli as intein-fusion proteins. The selected variants displayed a number of amino acid exchanges in the VP1-unique region and had mutations in the determined epitope and adjacent regions. After purification via affinity chromatography, the dissociation constants KD of VP1-specific human MAbs interacting with the variant antigens and a viral prototype of the VP1-unique region were determined with a quartz crystal microbalance biosensor. A value of 5·4x10-8 M was determined for the prototype isolate pJB; the affinity constants for the variant VP1-unique regions were similar. Comparable values were obtained for interaction of antibodies with non-infectious VP1/VP2 capsids produced by recombinant baculovirus and with B19 virions from amniotic fluid. It is concluded that the conformation of the epitope is unaffected by mutations or the environment of the VP1-unique region in virus capsids.




This article has been cited by other articles:


Home page
J. Virol.Home page
C. Bonsch, C. Kempf, and C. Ros
Interaction of Parvovirus B19 with Human Erythrocytes Alters Virus Structure and Cell Membrane Integrity
J. Virol., December 1, 2008; 82(23): 11784 - 11791.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. Ros, M. Gerber, and C. Kempf
Conformational Changes in the VP1-Unique Region of Native Human Parvovirus B19 Lead to Exposure of Internal Sequences That Play a Role in Virus Neutralization and Infectivity
J. Virol., December 15, 2006; 80(24): 12017 - 12024.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. Candotti, N. Etiz, A. Parsyan, and J.-P. Allain
Identification and Characterization of Persistent Human Erythrovirus Infection in Blood Donor Samples
J. Virol., November 15, 2004; 78(22): 12169 - 12178.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
A. R. Butchko and J. A. Jordan
Comparison of Three Commercially Available Serologic Assays Used To Detect Human Parvovirus B19-Specific Immunoglobulin M (IgM) and IgG Antibodies in Sera of Pregnant Women
J. Clin. Microbiol., July 1, 2004; 42(7): 3191 - 3195.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
E. D. Heegaard and K. E. Brown
Human Parvovirus B19
Clin. Microbiol. Rev., July 1, 2002; 15(3): 485 - 505.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Dorsch, G. Liebisch, B. Kaufmann, P. von Landenberg, J. H. Hoffmann, W. Drobnik, and S. Modrow
The VP1 Unique Region of Parvovirus B19 and Its Constituent Phospholipase A2-Like Activity
J. Virol., February 15, 2002; 76(4): 2014 - 2018.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2001 by the Society for General Microbiology.